16 January 2018
News and Views
Links and Services
The most recent issue of the Journal of Viral Hepatitis evaluated efficacy and safety of ribavirin or pegylated interferon-α in chronic hepatitis E.
Hepatitis E viral infection can lead to a chronic infection in immunocompromised patients, result
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors